0 Комментарии
0 Поделились
673 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Antibiotic Residue Test Kits Market Growth, Overview and Forecast Analysis By Fact.MRAntibiotic Residue Test Kits Market to Expand at a CAGR of 6.1% Through 2033, Driven by Rising Food Safety Standards and Animal-Derived Product Demand Rockville, Maryland, USA— According to Fact.MR The global antibiotic residue test kits market is witnessing steady growth momentum as food safety regulations and animal-derived food consumption intensify worldwide. According to...0 Комментарии 0 Поделились 294 Просмотры 0 предпросмотр
-
Antibiotic Stewardship Biomarkers Market Forecast and GrowthThe antibiotic stewardship biomarkers market is gaining momentum as healthcare systems worldwide focus on improving antibiotic usage and reducing the growing burden of antimicrobial resistance (AMR). Biomarkers play a crucial role in guiding clinical decisions by helping healthcare providers differentiate bacterial infections, monitor treatment responses, and optimize antibiotic therapies....0 Комментарии 0 Поделились 169 Просмотры 0 предпросмотр
-
Antibiotic Stewardship Biomarkers Market Forecast and GrowthThe antibiotic stewardship biomarkers market is gaining momentum as healthcare systems worldwide focus on improving antibiotic usage and reducing the growing burden of antimicrobial resistance (AMR). Biomarkers play a crucial role in guiding clinical decisions by helping healthcare providers differentiate bacterial infections, monitor treatment responses, and optimize antibiotic therapies....0 Комментарии 0 Поделились 185 Просмотры 0 предпросмотр
-
Global Ceftazidime Avibactam Market Insights & Growth Trends | CAGR 9.7% (2026–2034)According to a newly published market research report by 24LifeSciences, global Ceftazidime Avibactam market was valued at USD 1.2 billion in 2025 and is projected to reach USD 2.8 billion by 2034, growing at a compound annual growth rate (CAGR) of 9.7% during the forecast period 20262034. Ceftazidime Avibactam is a fixed-dose combination antibiotic incorporating ceftazidime (3rd...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Global Ceftazidime Avibactam Market Insights & Growth Trends | CAGR 9.7% (2026–2034)According to a newly published market research report by 24LifeSciences, global Ceftazidime Avibactam market was valued at USD 1.2 billion in 2025 and is projected to reach USD 2.8 billion by 2034, growing at a compound annual growth rate (CAGR) of 9.7% during the forecast period 20262034. Ceftazidime Avibactam is a fixed-dose combination antibiotic incorporating ceftazidime (3rd...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Global Neomycin Market Set to Reach USD 620 Million by 2034 Amid Rising Infection BurdenAccording to a new report from Intel Market Research, the global Neomycin market was valued at USD 420 million in 2025 and is projected to reach USD 620 million by 2034, growing at a steady CAGR of 4.1% during the forecast period (2026–2034). This growth is fueled by rising antibiotic demand in human healthcare and veterinary medicine, coupled with increasing prevalence of bacterial...0 Комментарии 0 Поделились 4Кб Просмотры 0 предпросмотр
-
Hospital-Acquired Disease Testing Market to Reach USD 724 Million by 2031 | CAGR 5.6%According to a newly published market research report by 24LifeSciences, global hospital-acquired disease testing market was valued at USD 498 million in 2024 and is projected to reach USD 724 million by 2031, growing at a compound annual growth rate (CAGR) of 5.6% during the forecast period 2026–2034. Hospital-acquired infections (HAIs), clinically significant as nosocomial...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр